Preliminary selective laser trabeculoplasty (SLT) intraocular pressure results in glaucoma patients in Burkina Faso

Preliminary selective laser trabeculoplasty (SLT) intraocular pressure results in glaucoma patients in Burkina Faso

Glaucoma is the leading cause of irreversible blindness in the world. The purpose of our study was to evaluate the tonometric results of SLT treatment in patients with glaucoma. This was a prospective study of patients with glaucoma who were seen from October 1, 2017 to July 31, 2018. All patients u...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal francais d'ophtalmologie 2021-03, Vol.44 (3), p.409-414
Hauptverfasser: Diallo, J W, Ahnoux-Zabsonré, A, Dolo-Traoré, M, Ilboudo, P, Sanou, J, Méda, N
Format: Artikel
Sprache:fre
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 414
container_issue 3
container_start_page 409
container_title Journal francais d'ophtalmologie
container_volume 44
creator Diallo, J W
Ahnoux-Zabsonré, A
Dolo-Traoré, M
Ilboudo, P
Sanou, J
Méda, N
description Glaucoma is the leading cause of irreversible blindness in the world. The purpose of our study was to evaluate the tonometric results of SLT treatment in patients with glaucoma. This was a prospective study of patients with glaucoma who were seen from October 1, 2017 to July 31, 2018. All patients underwent SLT of the inferior 180°. Intraocular pressure (IOP) was measured before and then at 1, 15, 30, 60, 90 and 120days after treatment. We studied 35 eyes of 31 patients. The mean age was 59.3 (±8.4years), range 43-77years. The mean IOP prior to SLT was 20.1mmHg (±7mmHg). One day after the laser, this decreased to 17.6mmHg (±8.4), for a percentage of drop of 12.4%. At 30days, it was 15.3mmHg (±5.4mmHg), i.e. a 23.9% decrease. After 60 and 90days, there was a drop of 13.9% and 15.4%, respectively. At 120days, 43.3% of treated eyes had a decrease of at least 20%. The main complication was increased IOP in 14.2% of cases. SLT reduces IOP and the number of glaucoma medications in patients. It appears to be a viable alternative in our countries. These results should be confirmed with a larger cohort and longer follow-up.
doi_str_mv 10.1016/j.jfo.2020.06.039
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2481136654</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2481136654</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-fb25d2d29e521fe9bd3a2ea4799dfadf5f8e00a37964f1cee154666f0d6296273</originalsourceid><addsrcrecordid>eNo1kEtLAzEUhYMgtmh_gBvJsi5mzGOSaZZarAoFBet6yMzcSGrmYTIR-u-NtK4O97uHezkHoWtKckqovNvnezPkjDCSE5kTrs7QnJYlz4hQ5QwtQrA1oUqyUgh6gWacF6pQJZ2j8ObB2c722h9wAAfNZH8AOx3A48nrGprohjHN0wEv37e7W2z7xIeEtcejhxCiB5w0uimkJf50OjZDp_GoJwv9ET5E_5We4I0OwxU6N9oFWJz0En1sHnfr52z7-vSyvt9mI6N0ykzNRMtapkAwakDVLdcMdFEq1RrdGmFWQIjmpZKFoQ0AFYWU0pBWsr-o_BItj3dHP3xHCFPV2dCAc7qHIYaKFStKuZSiSNabkzXWHbTV6G2XGqn-i-K_rdBsvA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2481136654</pqid></control><display><type>article</type><title>Preliminary selective laser trabeculoplasty (SLT) intraocular pressure results in glaucoma patients in Burkina Faso</title><source>Alma/SFX Local Collection</source><creator>Diallo, J W ; Ahnoux-Zabsonré, A ; Dolo-Traoré, M ; Ilboudo, P ; Sanou, J ; Méda, N</creator><creatorcontrib>Diallo, J W ; Ahnoux-Zabsonré, A ; Dolo-Traoré, M ; Ilboudo, P ; Sanou, J ; Méda, N</creatorcontrib><description>Glaucoma is the leading cause of irreversible blindness in the world. The purpose of our study was to evaluate the tonometric results of SLT treatment in patients with glaucoma. This was a prospective study of patients with glaucoma who were seen from October 1, 2017 to July 31, 2018. All patients underwent SLT of the inferior 180°. Intraocular pressure (IOP) was measured before and then at 1, 15, 30, 60, 90 and 120days after treatment. We studied 35 eyes of 31 patients. The mean age was 59.3 (±8.4years), range 43-77years. The mean IOP prior to SLT was 20.1mmHg (±7mmHg). One day after the laser, this decreased to 17.6mmHg (±8.4), for a percentage of drop of 12.4%. At 30days, it was 15.3mmHg (±5.4mmHg), i.e. a 23.9% decrease. After 60 and 90days, there was a drop of 13.9% and 15.4%, respectively. At 120days, 43.3% of treated eyes had a decrease of at least 20%. The main complication was increased IOP in 14.2% of cases. SLT reduces IOP and the number of glaucoma medications in patients. It appears to be a viable alternative in our countries. These results should be confirmed with a larger cohort and longer follow-up.</description><identifier>EISSN: 1773-0597</identifier><identifier>DOI: 10.1016/j.jfo.2020.06.039</identifier><identifier>PMID: 33494971</identifier><language>fre</language><publisher>France</publisher><ispartof>Journal francais d'ophtalmologie, 2021-03, Vol.44 (3), p.409-414</ispartof><rights>Copyright © 2021 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33494971$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Diallo, J W</creatorcontrib><creatorcontrib>Ahnoux-Zabsonré, A</creatorcontrib><creatorcontrib>Dolo-Traoré, M</creatorcontrib><creatorcontrib>Ilboudo, P</creatorcontrib><creatorcontrib>Sanou, J</creatorcontrib><creatorcontrib>Méda, N</creatorcontrib><title>Preliminary selective laser trabeculoplasty (SLT) intraocular pressure results in glaucoma patients in Burkina Faso</title><title>Journal francais d'ophtalmologie</title><addtitle>J Fr Ophtalmol</addtitle><description>Glaucoma is the leading cause of irreversible blindness in the world. The purpose of our study was to evaluate the tonometric results of SLT treatment in patients with glaucoma. This was a prospective study of patients with glaucoma who were seen from October 1, 2017 to July 31, 2018. All patients underwent SLT of the inferior 180°. Intraocular pressure (IOP) was measured before and then at 1, 15, 30, 60, 90 and 120days after treatment. We studied 35 eyes of 31 patients. The mean age was 59.3 (±8.4years), range 43-77years. The mean IOP prior to SLT was 20.1mmHg (±7mmHg). One day after the laser, this decreased to 17.6mmHg (±8.4), for a percentage of drop of 12.4%. At 30days, it was 15.3mmHg (±5.4mmHg), i.e. a 23.9% decrease. After 60 and 90days, there was a drop of 13.9% and 15.4%, respectively. At 120days, 43.3% of treated eyes had a decrease of at least 20%. The main complication was increased IOP in 14.2% of cases. SLT reduces IOP and the number of glaucoma medications in patients. It appears to be a viable alternative in our countries. These results should be confirmed with a larger cohort and longer follow-up.</description><issn>1773-0597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNo1kEtLAzEUhYMgtmh_gBvJsi5mzGOSaZZarAoFBet6yMzcSGrmYTIR-u-NtK4O97uHezkHoWtKckqovNvnezPkjDCSE5kTrs7QnJYlz4hQ5QwtQrA1oUqyUgh6gWacF6pQJZ2j8ObB2c722h9wAAfNZH8AOx3A48nrGprohjHN0wEv37e7W2z7xIeEtcejhxCiB5w0uimkJf50OjZDp_GoJwv9ET5E_5We4I0OwxU6N9oFWJz0En1sHnfr52z7-vSyvt9mI6N0ykzNRMtapkAwakDVLdcMdFEq1RrdGmFWQIjmpZKFoQ0AFYWU0pBWsr-o_BItj3dHP3xHCFPV2dCAc7qHIYaKFStKuZSiSNabkzXWHbTV6G2XGqn-i-K_rdBsvA</recordid><startdate>202103</startdate><enddate>202103</enddate><creator>Diallo, J W</creator><creator>Ahnoux-Zabsonré, A</creator><creator>Dolo-Traoré, M</creator><creator>Ilboudo, P</creator><creator>Sanou, J</creator><creator>Méda, N</creator><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>202103</creationdate><title>Preliminary selective laser trabeculoplasty (SLT) intraocular pressure results in glaucoma patients in Burkina Faso</title><author>Diallo, J W ; Ahnoux-Zabsonré, A ; Dolo-Traoré, M ; Ilboudo, P ; Sanou, J ; Méda, N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-fb25d2d29e521fe9bd3a2ea4799dfadf5f8e00a37964f1cee154666f0d6296273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Diallo, J W</creatorcontrib><creatorcontrib>Ahnoux-Zabsonré, A</creatorcontrib><creatorcontrib>Dolo-Traoré, M</creatorcontrib><creatorcontrib>Ilboudo, P</creatorcontrib><creatorcontrib>Sanou, J</creatorcontrib><creatorcontrib>Méda, N</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal francais d'ophtalmologie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Diallo, J W</au><au>Ahnoux-Zabsonré, A</au><au>Dolo-Traoré, M</au><au>Ilboudo, P</au><au>Sanou, J</au><au>Méda, N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preliminary selective laser trabeculoplasty (SLT) intraocular pressure results in glaucoma patients in Burkina Faso</atitle><jtitle>Journal francais d'ophtalmologie</jtitle><addtitle>J Fr Ophtalmol</addtitle><date>2021-03</date><risdate>2021</risdate><volume>44</volume><issue>3</issue><spage>409</spage><epage>414</epage><pages>409-414</pages><eissn>1773-0597</eissn><abstract>Glaucoma is the leading cause of irreversible blindness in the world. The purpose of our study was to evaluate the tonometric results of SLT treatment in patients with glaucoma. This was a prospective study of patients with glaucoma who were seen from October 1, 2017 to July 31, 2018. All patients underwent SLT of the inferior 180°. Intraocular pressure (IOP) was measured before and then at 1, 15, 30, 60, 90 and 120days after treatment. We studied 35 eyes of 31 patients. The mean age was 59.3 (±8.4years), range 43-77years. The mean IOP prior to SLT was 20.1mmHg (±7mmHg). One day after the laser, this decreased to 17.6mmHg (±8.4), for a percentage of drop of 12.4%. At 30days, it was 15.3mmHg (±5.4mmHg), i.e. a 23.9% decrease. After 60 and 90days, there was a drop of 13.9% and 15.4%, respectively. At 120days, 43.3% of treated eyes had a decrease of at least 20%. The main complication was increased IOP in 14.2% of cases. SLT reduces IOP and the number of glaucoma medications in patients. It appears to be a viable alternative in our countries. These results should be confirmed with a larger cohort and longer follow-up.</abstract><cop>France</cop><pmid>33494971</pmid><doi>10.1016/j.jfo.2020.06.039</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier EISSN: 1773-0597
ispartof Journal francais d'ophtalmologie, 2021-03, Vol.44 (3), p.409-414
issn 1773-0597
language fre
recordid cdi_proquest_miscellaneous_2481136654
source Alma/SFX Local Collection
title Preliminary selective laser trabeculoplasty (SLT) intraocular pressure results in glaucoma patients in Burkina Faso
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T08%3A43%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preliminary%20selective%20laser%20trabeculoplasty%20(SLT)%20intraocular%20pressure%20results%20in%20glaucoma%20patients%20in%20Burkina%20Faso&rft.jtitle=Journal%20francais%20d'ophtalmologie&rft.au=Diallo,%20J%20W&rft.date=2021-03&rft.volume=44&rft.issue=3&rft.spage=409&rft.epage=414&rft.pages=409-414&rft.eissn=1773-0597&rft_id=info:doi/10.1016/j.jfo.2020.06.039&rft_dat=%3Cproquest_pubme%3E2481136654%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2481136654&rft_id=info:pmid/33494971&rfr_iscdi=true